Fosun Pharma sells 6 percent stake in Gland Pharma via open market

Promoter Stake Sell 1pctPromoter Below 50pctOwnership Changes View source PDF Explain this filing

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹2972.00

prior close

₹2935.00

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.2%-0.6% vs market

Pharmaceuticals peers, median of 176sector+0.2%-0.6% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.7

15m

+0.6

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+0.2-0.6+0.2-0.6

Next day

+1.6-0.3+1.9-0.3+1.9

-0.7-0.3-0.5+0.0-0.8

-1.5-0.8-0.7-0.5-1.0

-2.1-3.2+1.1-2.0-0.2

-5.4-3.4-2.0-2.0-3.4

-0.7-1.1+0.3-0.9+0.2

15d

-2.3-3.7+1.5-1.8-0.4

+3.0-5.4+8.4-4.5+7.5

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 176Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Fosun Pharma Industrial Pte Ltd sold 98,97,000 shares (about 6%) of Gland Pharma through open market on September 4, 2026. Promoter holding dropped from 51.76% to 45.76%, falling below the 50% mark. The shares sold represent 5.95% of the diluted share capital.

Likely market impact

Promoter exits 6 percent and falls below 50% majority, signalling further divestment risk and reduced controlling stake.